Rxcurve
HCPCS J3060 · per 10 UNITS

Inj, taliglucerase alfa 10 u

Products billed under this code include Elelyso.

Payment limit per 10 UNITS, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J3060

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Elelyso Pfizer Inc 00069-0106-01 20 $849.46

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $42.473 −$0.202 10 UNITS Inj, taliglucerase alfa 10 u v1, posted September 17, 2026
3Q26 $42.675 +$2.018 10 UNITS Inj, taliglucerase alfa 10 u v1, posted September 15, 2026
2Q26 $40.657 −$0.286 10 UNITS Inj, taliglucerase alfa 10 u v1, posted September 15, 2026
1Q26 $40.943 −$0.167 10 UNITS Inj, taliglucerase alfa 10 u v1, posted September 15, 2026
4Q25 $41.11 +$0.046 10 UNITS Inj, taliglucerase alfa 10 u v1, posted September 8, 2026
3Q25 $41.064 +$0.422 10 UNITS Inj, taliglucerase alfa 10 u v1, posted March 10, 2026
2Q25 $40.642 −$0.979 10 UNITS Inj, taliglucerase alfa 10 u v1, posted March 10, 2026
1Q25 $41.621 −$0.96 10 UNITS Inj, taliglucerase alfa 10 u v1, posted December 19, 2025
4Q24 $42.581 −$1.989 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 11, 2025
3Q24 $44.57 −$0.43 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 11, 2025
2Q24 $45.00 −$0.034 10 UNITS Inj, taliglucerase alfa 10 u v1, posted March 11, 2025
1Q24 $45.034 −$0.141 10 UNITS Inj, taliglucerase alfa 10 u v1, posted December 19, 2024
4Q23 $45.175 +$0.614 10 UNITS Inj, taliglucerase alfa 10 u v1, posted October 10, 2024
3Q23 $44.561 +$1.645 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 5, 2024
2Q23 $42.916 +$0.921 10 UNITS Inj, taliglucerase alfa 10 u v1, posted February 23, 2024
1Q23 $41.995 +$0.092 10 UNITS Inj, taliglucerase alfa 10 u v1, posted December 6, 2023
4Q22 $41.903 +$0.218 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 22, 2023
3Q22 $41.685 +$1.333 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 9, 2023
2Q22 $40.352 −$0.877 10 UNITS Inj, taliglucerase alfa 10 u v1, posted December 14, 2022
1Q22 $41.229 −$0.093 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 8, 2022
4Q21 $41.322 −$0.058 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 2, 2022
3Q21 $41.38 +$0.305 10 UNITS Inj, taliglucerase alfa 10 u v1, posted June 2, 2022
2Q21 $41.075 +$0.111 10 UNITS Inj, taliglucerase alfa 10 u v1, posted March 1, 2022
1Q21 $40.964 – 10 UNITS Inj, taliglucerase alfa 10 u v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files